DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
1-Year Return
0.48%
This Quarter Return
+38.59%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$144M
AUM Growth
+$17.4M
(+14%)
Cap. Flow
-$21.6M
Cap. Flow
% of AUM
-15.05%
Top 10 Holdings %
Top 10 Hldgs %
45.16%
Holding
105
New
9
Increased
14
Reduced
21
Closed
29
Top Buys
| 1 |
Tandem Diabetes Care
TNDM
|
$3.15M |
| 2 |
Protagonist Therapeutics
PTGX
|
$2.62M |
| 3 |
Ardelyx
ARDX
|
$2.45M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$2.43M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
$2.25M |
Top Sells
| 1 |
Rigel Pharmaceuticals
RIGL
|
$5.53M |
| 2 |
AbbVie
ABBV
|
$4.73M |
| 3 |
Novavax
NVAX
|
$4M |
| 4 |
DERM
Dermira, Inc.
DERM
|
$3.21M |
| 5 |
NXTM
NxStage Medical Inc.
NXTM
|
$2.95M |
Sector Composition
| 1 | Healthcare | 68.48% |
